Enteric Empty Capsules Market End user , Supply Distributors | Analyst Market and Trend Forecast(2025 - 2032)
Enteric Empty Capsules Market Analysis Report Overview :
The
enteric empty capsules market focuses on the manufacturing and distribution
of empty capsules designed to resist dissolution in the stomach's acidic
environment but dissolve in the more alkaline environment of the small
intestine. This delayed-release mechanism is crucial for delivering drugs that
are sensitive to stomach acid, target specific areas of the intestine, or cause
gastric irritation. These capsules are primarily used in the pharmaceutical and
nutraceutical industries. The market is driven by the increasing demand for
targeted drug delivery, the growing prevalence of gastrointestinal disorders,
and advancements in capsule manufacturing technologies.
Key Drivers :
Several key trends are shaping the enteric empty capsules
market:
·
Growing Demand for Targeted Drug Delivery: The increasing
focus on targeted drug delivery to improve drug efficacy and reduce side
effects is driving demand for enteric capsules.
·
Rising Prevalence of Gastrointestinal Disorders:
The increasing prevalence of gastrointestinal disorders, such as irritable bowel
syndrome (IBS) and inflammatory bowel disease (IBD), is fuelling demand for
enteric capsules to deliver targeted therapies to the intestines.
·
Advancements in Polymer Technology: Advancements
in polymer technology are leading to the development of new enteric polymers
with improved performance characteristics, such as enhanced acid resistance and
controlled release profiles.
·
Increasing Use in Nutraceuticals: Enteric
capsules are increasingly used in the nutraceutical industry to protect
sensitive ingredients, such as probiotics and enzymes, from stomach acid.
·
Enteric empty capsules are largely essential for
providing supplements and medications in treating chronic diseases.
·
Owing to certain features of the capsules such
as accurate dosage and compatibility with different kinds of drugs, the
capsules are largely required in treatments for chronic conditions.
·
Enteric empty capsules are largely essential for
providing supplements and medications in treating chronic diseases.
Key Restraints :
The enteric empty capsules market faces certain restraints:
·
Cost of Enteric Coating: Applying enteric
coatings to capsules can increase manufacturing costs compared to standard
capsules.
·
Challenges in Achieving Consistent Enteric
Performance: Achieving consistent enteric performance, ensuring that capsules
dissolve only in the intended part of the intestine, can be technically
challenging.
·
Regulatory Requirements and Compliance:
Manufacturers must comply with strict regulatory requirements and quality
standards for pharmaceutical and nutraceutical products, including enteric
capsules.
·
Material Compatibility: Ensuring compatibility
between the enteric coating material and the encapsulated drug or ingredient is
crucial for maintaining product stability and efficacy.
·
Enteric empty capsules have gelatin as the most
common material used in the production process. Gelatin is prepared from
collagen, which is made from the by-products of slaughtered animals which
include bones, hides, hooves of cattle, fish, pigs, horses, and others.
Future Opportunities:
The enteric empty capsules market presents several
opportunities:
·
Development of Novel Enteric Polymers: Continued
research and development of new enteric polymers with improved performance
characteristics, such as pH-dependent release profiles and enhanced stability.
·
Focus on Plant-Based and Vegetarian Capsules:
The growing demand for plant-based and vegetarian products is driving demand
for enteric capsules made from plant-derived materials.
·
Development of Multi-Particulate Delivery
Systems: Exploring the use of enteric capsules for multi-particulate delivery
systems, which can provide more controlled and sustained drug release.
·
Expansion into Emerging Markets: The growing
pharmaceutical and nutraceutical
industries in emerging economies present opportunities for enteric capsule
manufacturers to expand their market presence.
·
The high efficiency and speed of the automated
capsule filling machines is bringing in growing production capacity and
reduction in manufacturing costs
·
They launched a new product named EUDRACAP,
which is suitable for early drug development stages through a commercial scale
and by using sensitive molecules.
·
Different innovations in capsule manufacturing
technology such as the development of automated capsule filling machines and
others are expected to boost the enteric empty capsules market opportunities
and trends further.
Segmentation:
The enteric empty capsules market can be segmented based on:
Polymer Type:
·
Cellulose-based Polymers (e.g., HPMC, CAP)
·
Acrylic Polymers (e.g., Eudragit)
·
Other Polymers
Capsule Size:
·
Various standard capsule sizes (e.g., 00, 0, 1,
2)
·
Application:
·
Pharmaceuticals
·
Nutraceuticals
End-User:
·
Pharmaceutical and Biopharmaceutical Companies
·
Cosmetic Companies,
·
Nutraceutical Companies
·
Clinical Research Organizations
·
Others
Region:
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Key Players :
The enteric empty capsules market includes specialized
capsule manufacturers and larger pharmaceutical and nutraceutical suppliers.
Some key players include:
·
Lonza Group Ltd, Evonik
·
The Roxlor Group,
·
CapsCanada Corporation
·
Qualicaps Inc.
·
CapsulCN International Co., Ltd.,
·
Natural Capsules Limited, Snail Pharma Industry
Co. Ltd.
·
ACG Group, and Anhui Huangshan Capsule Co., Ltd.
Regional Analysis :
North America and Europe represent significant markets due
to well-established pharmaceutical and nutraceutical industries and stringent
regulatory standards. The Asia-Pacific region is expected to witness
significant growth due to increasing pharmaceutical
production and rising demand for nutraceutical products.
In 2024, North America accounted for the highest market
share at 33.56%, valued at USD 27.57 million and is projected to grow to USD
29.31 million in 2025, it is expected to reach USD 50.84 Million in 2032. In
North America, the U.S. accounted for the highest market share of 86.23% during
the base year 2024.
Recent Developments :
Development of Enteric Capsules with Targeted Release in
Specific Regions of the Intestine: Research is focused on developing enteric
capsules that can release their contents in specific regions of the small
intestine, such as the duodenum or ileum.
Focus on Improving Capsule Stability and Shelf Life: Efforts
are being made to improve the stability and shelf life of enteric capsules,
particularly under different storage conditions.
Increased Use of Biopolymers for Enteric Coatings: The use
of biopolymers, such as chitosan and alginate, for enteric coatings is being
explored due to their biocompatibility and biodegradability.
Contact us:
Consegic
Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Other Reports :
Acute
Coronary Syndrome Market
Cloud
Communication Platform Market
Multi-vendor
Support Services Market
Comments
Post a Comment